Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Story1
Karyopharm files for Chapter 11 with up to $110 million of new financing and plans to cancel its existing shares
SEC filings show Karyopharm Therapeutics filed Chapter 11 petitions in Texas on 2 November with a restructuring support agreement backed by all of its funded debt holders.
Company or person29
Karyopharm Therapeutics Inc.
Company
Kailera Therapeutics, Inc.
Company
THC Therapeutics, Inc.
Company
Kalaris Therapeutics, Inc.
Company
C4 Therapeutics, Inc.
Company
Kymera Therapeutics, Inc.
Company
Keros Therapeutics, Inc.
Company
AN2 Therapeutics, Inc.
Company
Turn Therapeutics Inc.
Company
PTC THERAPEUTICS, INC.
Company
Vera Therapeutics, Inc.
Company
vTv Therapeutics Inc.
Company
Nuo Therapeutics, Inc.
Company
TherapeuticsMD, Inc.
Company
MiNK Therapeutics, Inc.
Company
Tango Therapeutics, Inc.
Company
Dyne Therapeutics, Inc.
Company
FATE THERAPEUTICS INC
Company
Rein Therapeutics, Inc.
Company
Ovid Therapeutics Inc.
Company
Coya Therapeutics, Inc.
Company
CITY THERAPEUTICS, INC.
Company
TScan Therapeutics, Inc.
Company
Maze Therapeutics, Inc.
Company
Gain Therapeutics, Inc.
Company
TENAX THERAPEUTICS, INC.
Company
Beam Therapeutics Inc.
Company
GYRE THERAPEUTICS, INC.
Company
LENZ Therapeutics, Inc.
Company